期刊文献+

顺铂联合足叶乙甙对卵巢癌SKOV3细胞的增殖抑制作用及机制探讨 被引量:2

Proliferation inhibition and mechanism about cisplatin combined with etoposide on ovarian cancer cell line SKOV3
下载PDF
导出
摘要 目的观察顺铂联合足叶乙甙(PE方案)对卵巢癌细胞增殖和细胞周期的影响,并探讨其作用机制。方法体外培养的卵巢癌SKOV3细胞,加入不同浓度的顺铂和足叶乙甙,作用24 h。MTT法检测细胞抑制率;流式细胞仪测定细胞周期,免疫细胞化学法检测细胞的Cyclin B1、p34cdc2和survivin。结果足叶乙甙和不同浓度的顺铂联合应用,可明显抑制SKOV3细胞的增殖,S期和G2-M期细胞增加,G0-G1期细胞减少,细胞Cyclin B1、p34cdc2和survivin表达下调。结论顺铂联合足叶乙甙对SKOV3细胞具有协同抑制作用,阻滞细胞周期,其机制可能与细胞Cyclin B1p、34cdc2和survivin的表达下调有关。 Objective To observe the effect of cisplatin combined with etoposide on the proliferation and cell cycle of human ovarian carcinoma cell line, and investigate the mechanisms. Methods Ovarian cancer cell line SKOV3 was interfered with cisplatin and etoposide in different concentration for 24 h.The proliferation inhibition rate was measured by MTT, the cell cycles were analyzed by the flow cytometry, the C yclin Bi , p34^cdc2 and survivin were determined by immunnhistochemistry method. Results Etoposide combined with different concentration cisplatin inhibited the proliferation of SKOV3 cell, S and G2 - M phase cell percentage increased, while Go - G1 phase decreased, the expression of Cyclin B1, p34^cdc2 and survivin were decreased. Conclusions Etoposide combined with cisplatin shows significant synergistic inhibition on SKOV3 cell line, the mechanism may be related with the degressive expression of Cyclin B1 , p34^cdc2 and survivin.
出处 《山东医药》 CAS 北大核心 2008年第33期8-9,共2页 Shandong Medical Journal
基金 河北省石家庄市科技发展计划基金资助项目(08146693)
关键词 顺铂 足叶乙甙 卵巢癌细胞 细胞周期 细胞周期蛋白 cisplatin etoposide ovarian carcinoma cell cell cycle cell cycle proteins
  • 相关文献

参考文献4

  • 1梁利波,千新来,马业伟,王争,刘玉英,赵清正.E1A基因对人肺腺癌细胞增殖和细胞周期的影响[J].中华结核和呼吸杂志,2001,24(11):663-665. 被引量:7
  • 2Morgan DO. Principles of CDK regulation [J]. Nature, 1995,374(6518) : 131-134.
  • 3Doi T, Morita T, Wakabayashi N,et al.Induction of instability of p34 ex- pression by treatment with cisplatin in mouse teratocarcinoma 179 cells [ J]. Cancer Lett, 2002,176 ( 1 ) : 75-80.
  • 4Connor DS, Wall NR, Porter AC, et al.A p34rdc2 survival checkpoint in cancer[J]. Cancer Cell, 2002,2 ( 1 ) :43-54.

二级参考文献6

共引文献6

同被引文献12

  • 1常璇,陆爱梅,潘婷.30例应用CDV方案化疗的晚期神经母细胞瘤患儿的护理[J].中华现代护理杂志,2007,13(30):2863-2864. 被引量:4
  • 2冯晨,唐锁勤,黄东生,王建文,于芳,杨光.CEM为预处理方案的自体外周血造血干细胞移植治疗晚期神经母细胞瘤相关毒性及疗效观察[J].中国当代儿科杂志,2004,6(6):489-491. 被引量:3
  • 3唐锁勤,黄东生,王建文,冯晨,杨光.大剂量化疗造血干细胞移植治疗IV期神经母细胞瘤的长期疗效研究[J].中国当代儿科杂志,2006,8(2):93-96. 被引量:27
  • 4崔慧娟,李京华,李欧静,李佩文.原始神经外胚层瘤10年国内文献分析[J].疑难病杂志,2007,6(4):216-219. 被引量:37
  • 5Schwab M, Westermann F, Hero B, Berthold F. Neuroblastoma: biology and molecular and chromosomal pathology[J]. Lancet Oncol, 2003, 4(8):472-480.
  • 6Castel V, Tovar JA, Costa E, Cuadros J, Ruiz A, Rollan V, et al. The role of surgery in stage Ⅳ neuroblastoma [J]. J Pediatr Surg, 2002, 37(11):1574-1578.
  • 7Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK. Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma [J]. J Clin Oncol, 2004, 22(24) :4888-4892.
  • 8McWilliams NB, Hayes FA, Green AA, Smith El, Nitschke R, Ahshuler GA, et al. Cyclophosphamide/doxorubicin vs. cisplatin/ teuiposide in the treatment of children older than 12 months of age with disseminated neuroblastoma:a Pediatric Oncology Group Randomized Phase Ⅱ study [ J ]. Med Pediatr Oncol, 1995, 24 (3) : 176-180.
  • 9Kushner BH, Kramer K, Modak S, Qin LX, Yataghena K, Jhanwar SC, et al. Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma[J]. Pediatr Blood Cancer, 2009, 53 ( 1 ) : 17-22.
  • 10Paul C,Tidefeh U, Liliemark J. et al. Increasing the accumulation of daunorubicin in human leukemic cells by prolonging the infusion time [ J ]. Leuk Res, 1989,13 (2) : 191 - 196.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部